EpiVax Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

EpiVax Therapeutics General Information

Description

Operator of a clinical research and development platform intended to offer precision cancer immunotherapies. The company's platform is based on optimal neo-epitopes selected through proprietary and validated in-silico predictive algorithms, enabling clients to address the unmet medical needs that are inadequately addressed by current cancer therapeutic approaches.

Contact Information

Formerly Known As
EpiVax Oncology
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 188 Valley Street
  • Suite 424
  • Providence, RI 02909
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 188 Valley Street
  • Suite 424
  • Providence, RI 02909
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiVax Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 02-Apr-2026 Completed Out of Business
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 26-Jan-2022 Completed Generating Revenue
5. Early Stage VC (Series A) 22-Feb-2021 Completed Generating Revenue
4. Seed Round 25-May-2018 Completed Startup
3. Seed Round 25-Sep-2017 Completed Startup
2. Accelerator/Incubator 12-Dec-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view EpiVax Therapeutics’s complete valuation and funding history, request access »

EpiVax Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical research and development platform intended to offer precision cancer immunotherapies. The company
Drug Discovery
Providence, RI
3 As of 2024

Emeryville, CA
 

Mainz, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiVax Therapeutics Competitors (2)

One of EpiVax Therapeutics’s 2 competitors is Nexoplex bio, a Formerly VC-backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nexoplex bio Formerly VC-backed Emeryville, CA
BioNTech Formerly VC-backed Mainz, Germany
You’re viewing 2 of 2 competitors. Get the full list »

EpiVax Therapeutics Patents

EpiVax Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210145951-A1 Compositions and methods for shared neo-epitope vaccines Inactive 18-Nov-2019
CA-3158646-A1 Improved compositions and methods for shared neo-epitope vaccines Pending 18-Nov-2019
EP-4062177-A1 Improved compositions and methods for shared neo-epitope vaccines Inactive 18-Nov-2019
US-20220362365-A1 Improved compositions and methods for shared neo-epitope vaccines Inactive 18-Nov-2019
WO-2021101962-A1 Improved compositions and methods for shared neo-epitope vaccines Inactive 18-Nov-2019 G01N33/575
To view EpiVax Therapeutics’s complete patent history, request access »

EpiVax Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EpiVax Therapeutics FAQs

  • When was EpiVax Therapeutics founded?

    EpiVax Therapeutics was founded in 2017.

  • Where is EpiVax Therapeutics headquartered?

    EpiVax Therapeutics is headquartered in Providence, RI.

  • What is the size of EpiVax Therapeutics?

    EpiVax Therapeutics has 3 total employees.

  • What industry is EpiVax Therapeutics in?

    EpiVax Therapeutics’s primary industry is Drug Discovery.

  • Is EpiVax Therapeutics a private or public company?

    EpiVax Therapeutics is a Private company.

  • What is EpiVax Therapeutics’s current revenue?

    The current revenue for EpiVax Therapeutics is .

  • How much funding has EpiVax Therapeutics raised over time?

    EpiVax Therapeutics has raised $3.07M.

  • Who are EpiVax Therapeutics’s competitors?

    Nexoplex bio and BioNTech are competitors of EpiVax Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process